Anti-Synoviolin Antibody
AssigneeLocomogene, Inc.
InventorsToshihiro Nakajima, Satoshi Yamasaki, Lei Zhang, Tetsuya Amano
Life of this patent
Estimating the term…
Abstract
The present invention relates to an antibody against synoviolin or a fragment thereof for providing a monoclonal antibody capable of recognizing a part of synoviolin, which monoclonal antibody is capable of inhibiting the auto-ubiquitination of synoviolin.
Claims18
An antibody or a fragment thereof against synoviolin, said antibody being capable of inhibiting auto-ubiquitination of synoviolin.
A monoclonal antibody against synoviolin or a fragment thereof produced by a hybridoma obtained by cell fusion between a myeloma cell and an antibody-producing cell derived from an animal immunized with a peptide having an amino acid sequence represented by any one of SEQ ID NOS:3-5 as an antigen, said monoclonal antibody being capable of inhibiting auto-ubiquitination of synoviolin.
A hybridoma obtained by cell fusion between a myeloma cell and an antibody-producing cell derived from an animal immunized with a peptide having an amino acid sequence represented by any one of SEQ ID NOS:3-5 as an antigen, said hybridoma producing a monoclonal antibody capable of inhibiting auto-ubiquitination of synoviolin.
A method for producing a monoclonal antibody against synoviolin, comprising:
- culturing a fusion cell between a myeloma cell and an antibody-producing cell derived from an animal immunized with a peptide having an amino acid sequence represented by any one of SEQ ID NOS:
- 3-5 as an antigen;
- and collecting the monoclonal antibody from the resulting culture, wherein said monoclonal antibody is capable of inhibiting auto-ubiquitination of synoviolin.
(canceled)
11-13. (canceled)
Dependencies are inferred from the claim text.